Sar and in Vivo Evaluation of 4-Aryl-2-Aminoalkylpyrimidines as Potent and Selective Janus Kinase 2 (Jak2) Inhibitors
Forsyth, T., Kearney, P.C., Kim, B.G., Johnson, H.W.B., Aay, N., Arcalas, A., Brown, D.S., Chan, V., Chen, J., Du, H., Epshteyn, S., Galan, A.A., Huynh, T.P., Ibrahim, M.A., Kane, B., Koltun, E., Mann, G., Meyr, L.E., Lee, M.S., Lewis, G.L., Noguchi, R.T., Pack, M., Ridgway, B.H., Shi, X., Takeuchi, C.S., Zu, P., Leahy, J.W., Nuss, J.M., Aoyama, R., Engst, S., Gendreau, S.B., Kassees, R., Li, J., Lin, S.-H., Martini, J.-F., Stout, T., Tong, P., Woolfrey, J., Zhang, W., Yu, P.(2012) Bioorg Med Chem Lett 22: 7653
- PubMed: 23127890 
- DOI: https://doi.org/10.1016/j.bmcl.2012.10.007
- Primary Citation of Related Structures:  
4BBE, 4BBF - PubMed Abstract: 
We report the discovery of a series of 4-aryl-2-aminoalkylpyrimidine derivatives as potent and selective JAK2 inhibitors. High throughput screening of our in-house compound library led to the identification of hit 1, from which optimization resulted in the discovery of highly potent and selective JAK2 inhibitors ...